Cargando…

A global collaboration to advance vaccine product innovations – The Vaccine Innovation Prioritisation Strategy

Detalles Bibliográficos
Autores principales:	Kristensen, Debra, Giersing, Birgitte, Hickling, Julian, Kazi, Fatima, Scarna, Tiziana, Kahn, Anna-Lea, Hsu, Vivian, Gandrup-Marino, Kristoffer, Menozzi-Arnaud, Marion
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222942/ https://www.ncbi.nlm.nih.gov/pubmed/34175125 http://dx.doi.org/10.1016/j.vaccine.2021.05.102

Ejemplares similares

Vaccine innovation prioritisation strategy: Findings from three country-stakeholder consultations on vaccine product innovations
por: Mvundura, Mercy, et al.
Publicado: (2021)

Strategies for vaccine-product innovation: Creating an enabling environment for product development to uptake in low- and middle-income countries
por: Giersing, Birgitte, et al.
Publicado: (2021)

How can we evaluate the potential of innovative vaccine products and technologies in resource constrained settings? A total systems effectiveness (TSE) approach to decision-making
por: Botwright, Siobhan, et al.
Publicado: (2020)

‘It takes two to tango’: Bridging the gap between country need and vaccine product innovation
por: Archer, Rachel A., et al.
Publicado: (2020)

What Drives the Value of a Shigella Vaccine?
por: Hausdorff, William P., et al.
Publicado: (2022)

Vaccines, inspiring innovation in health()
por: Pagliusi, Sonia, et al.
Publicado: (2018)

Innovation policy and the market for vaccines
por: Xue, Qiwei Claire, et al.
Publicado: (2020)

Vaccination as an Equaliser? Evaluating COVID-19 Vaccine Prioritisation and Compensation
por: Günther, Christian, et al.
Publicado: (2022)

Unleashing Innovation With Collaboration Platforms
por: Magni, Massimo
Publicado: (2019)

Exploring potential applications of measles and rubella microarray patches (MR-MAPs): use case identification
por: Malvolti, Stefano, et al.
Publicado: (2023)

COVID-19 vaccine prioritisation for people with disabilities
por: Epstein, Sabrina, et al.
Publicado: (2021)

Who should be prioritised for COVID-19 vaccines?
por: Hassan-Smith, Zaki, et al.
Publicado: (2020)

Prioritise people with HIV for COVID-19 vaccination
por: HIV, The Lancet
Publicado: (2021)

COVID-19 vaccine prioritisation for individuals with psychoses
por: Kumar, Sonali, et al.
Publicado: (2021)

Who should be prioritised for COVID-19 vaccination?
por: Russell, Fiona M, et al.
Publicado: (2020)

Prioritising health service innovation investments using public preferences: a discrete choice experiment
por: Erdem, Seda, et al.
Publicado: (2014)

Rapid prioritisation of topics for rapid evaluation: the case of innovations in adult social care and social work
por: Cowan, Katherine, et al.
Publicado: (2021)

Flavivirus vaccines: Innovate, invest, implement
Publicado: (2016)

Innovations in HIV-1 Vaccine Design
por: Jones, Letitia D., et al.
Publicado: (2020)

mRNA Innovates the Vaccine Field
por: Pardi, Norbert
Publicado: (2021)

Considerations for using ETEC and Shigella disease burden estimates to guide vaccine development strategy
por: Hosangadi, Divya, et al.
Publicado: (2019)

The jazz process: collaboration, innovation, and agility
por: Cho, Adrian
Publicado: (2010)

Revealing the Intricate Effect of Collaboration on Innovation
por: Inoue, Hiroyasu, et al.
Publicado: (2015)

Collaborative networks to achieve innovations in care
por: Catharine Craven, B., et al.
Publicado: (2021)

COVID-19 vaccine prioritisation for people with cystic fibrosis
por: Carr, Siobhán B, et al.
Publicado: (2021)

Considering gender-based violence in vaccine prioritisation strategies
por: Chandan, Joht Singh, et al.
Publicado: (2021)

Exploring the ethics of genetic prioritisation for COVID-19 vaccines
por: Bruce, Jago, et al.
Publicado: (2022)

Acute coronary syndromes with high thrombotic burden: therapeutic innovations
por: Menozzi, Alberto, et al.
Publicado: (2020)

Indian vaccine innovation: the case of Shantha Biotechnics
por: Chakma, Justin, et al.
Publicado: (2011)

Emerging vaccine manufacturers are innovating for the next decade
por: Hayman, Benoit, et al.
Publicado: (2020)

Vaccine Innovation Meta-Model for Pandemic Contexts
por: Fialho, Beatriz C., et al.
Publicado: (2023)

Innovative Ecosystem Model of Vaccine Lifecycle Management
por: Ilin, Igor, et al.
Publicado: (2022)

Knowledge management and innovation: interaction, collaboration, openness
por: Barbaroux, Pierre, et al.
Publicado: (2016)

Necessity Is the Mother of Innovation–The Time to Collaborate Is Now
por: Luc, Jessica G.Y., et al.
Publicado: (2020)

Updates in SJS/TEN: collaboration, innovation, and community
por: Marks, Madeline E., et al.
Publicado: (2023)

COVID-19 Vaccine Prioritisation for Medical Students: The Forgotten Cohort?
por: Lim, J.S., et al.
Publicado: (2021)

The Full Value of Vaccine Assessments (FVVA): a framework for assessing and communicating the value of vaccines for investment and introduction decision-making
por: Hutubessy, Raymond, et al.
Publicado: (2023)

Evolving pharmacovigilance requirements with novel vaccines and vaccine components
por: Zuber, Patrick L F, et al.
Publicado: (2021)

Collaborative Innovation Network, Knowledge Base, and Technological Innovation Performance-Thinking in Response to COVID-19
por: Jialu, Su, et al.
Publicado: (2021)

How the pandemic has changed innovation collaboration in SMEs, as illustrated by four co-innovation projects
por: Blais, Caroline, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vadp6otn21ek13acmlo229ehvt